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Abstract
AIM: To identify possible risk factors and their syner-
gism for cholangiocarcinoma development.
METHODS: A hospital-based, case-control study in 
which we included 276 cholangiocarcinoma patients 
[193 extrahepatic cholangiocarcinoma (ECC) and 83 
intrahepatic cholangiocarcinoma (ICC)], diagnosed at 
a training hospital in Korea between 2007 and 2013, 
and 552 healthy controls matched 2:1 for age, sex, and 
date of diagnosis. Risk factors for cholangiocarcinoma 
and possible synergism between those factors were 
evaluated using conditional logistic regression and 
synergism index, respectively.
RESULTS: There was an association between 
cholangiocarcinoma and hepatitis B virus (HBV) 
infection, diabetes mellitus (DM), cholecystolithiasis, 
choledocholithiasis, and hepatolithiasis, with the 
adjusted odds ratios (AORs) of 4.1, 2.6, 1.7, 12.4, and 
39.9, respectively. Synergistic interaction on the additive 
model was investigated between HBV infection and 
DM (AOR = 12.2; 95%CI: 1.9-80.1). In the subgroup 
analyses, cholecystolithiasis, choledocholithiasis, 
hepatolithiasis, and DM were significant risk factors for 
ECC (AOR = 2.0, 18.1, 14.9, and 2.0, respectively), 
whereas choledocholithiasis, hepatolithiasis, HBV 
infection, and DM were risk factors for ICC (AOR = 8.6, 
157.4, 5.3 and 4.9, respectively). Synergistic interaction 
was also observed between HBV infection and DM (OR 
= 22.7; 95%CI: 2.4-214.1). However, there was no 
synergistic interaction between other significant risk 
factors for cholangiocarcinoma.
CONCLUSION: In this Korean study, HBV infection 
and DM were found to exert independent and syner-
gistic effects on the risk for cholangiocarcinoma, in-
cluding ICC. Exploring the underlying mechanisms 
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Case Control Study
Hepatitis B virus infection, diabetes mellitus, and their 
synergism for cholangiocarcinoma development: A case-
control study in Korea
For the other primary liver cancer such as hepato-
cellular carcinoma, several synergistic effects between 
risk factors have been identified[12,13]. However, there 
have been little studies to focus on analyzing inter-
actions between risk factors for CCA. Because of  the 
multifactorial nature of  biliary tract carcinogenesis, 
possible interactions between risk factors may exist. 
Therefore, we conducted a hospital-based case-control 
study to assess potential risk factors for CCA in Korea, 
and further evaluate possible synergisms between the risk 
factors identified.
MATERIALS AND METHODS
Study population
All patients diagnosed with CCA through pathological 
findings at the Cheju Halla General Hospital between 
January 2007 and April 2013 were reviewed for study 
enrollment. Pathological confirmation was based on 
definite cytology, small biopsy, or surgical pathology. 
Individuals diagnosed with other cancers before the date 
of  CCA diagnosis were excluded from enrollment.
Control subjects, matched 2:1 with cases for age 
(± 3 years), sex, and date of  diagnosis (± 3 mo), were 
randomly chosen among individuals who had visited 
the health screening center of  the Cheju Halla General 
Hospital for a routine checkup during the same period 
as the CCA cases. We excluded subjects with diagnoses 
of  cancers or who were missing any data regarding 
risk factors and cancers. Subjects without radiologic 
informations were also excluded. Finally, 276 cases and 
552 controls were included for the analysis. The study 
protocol was approved by the Institutional Review Board 
of  Cheju Halla General Hospital.
Data collection
Cases and controls were interviewed at the initial visit 
on their medical history, smoking, and alcohol use. 
Structured data collection sheets were routinely used in 
health screening center to obtain data on demographic 
and clinical characteristics. All eligible participants 
underwent radiological evaluations (abdominal ultra-
sound, computed tomography, and/or magnetic reso-
nance cholangiopancreatography). Blood samples were 
also collected from all subjects at the time of  initial 
examination.
All variables investigated for CCA risk evaluation 
were divided into 4 broad categories: biliary tract con-
ditions, infectious etiologies, non-infectious liver 
diseases, and miscellaneous potential risk factors. Bi-
liary tract conditions included cholecystolithiasis, chole-
docholithiasis, hepatolithiasis, cholecystectomy, primary 
sclerosing cholangitis, choledochal cyst, and liver fluke 
infestation. Non-infectious liver diseases included non-
specific liver cirrhosis and alcoholic hepatitis. The 
infectious diseases group included HBV infection and 
hepatitis C virus (HCV) infection. The miscellaneous 
potential risk factors included smoking, alcohol, obesity, 
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for such synergy may lead to the development of 
cholangiocarcinoma prevention strategies in high-risk 
individuals.
Key words: Cholangiocarcinoma; Risk factor; Hepatitis; 
Synergism; Diabetes mellitus
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Core tip: Although several risk factors for cholan-
giocarcinoma were identified in previous studies, 
details on their interactions or the influence of disease 
duration on the risk of cholangiocarcinoma are still 
unclear. Moreover, epidemiologic studies about cho-
langiocarcinoma in Korea are scarce. The present stu-
dy in a Korean population showed that the impact of 
diabetes mellitus on the risk of cholangiocarcinoma 
was greater when diabetic complications were present. 
Further, it indicated that there was a synergistic effect 
between Hepatitis B virus infection and diabetes 
mellitus on the risk of cholangiocarcinoma, and that the 
synergistic effect was enhanced in cases of complicated 
diabetes.
Lee BS, Park EC, Park SW, Nam CM, Roh J. Hepatitis B 
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INTRODUCTION
Cholangiocarcinomas (CCAs) are highly fatal cancers 
of  the biliary tract epithelium, which arise from intra-
hepatic [intrahepatic cholangiocarcinoma (ICC)] or 
extrahepatic bile ducts [extrahepatic cholangiocarcinoma 
(ECC)]. Although a rare malignancy, CCA is the second 
most common cancer of  the liver[1]. Furthermore, the 
incidence of  CCA has reportedly been increasing in 
several areas worldwide, especially the incidence of  
intrahepatic CCA[2-4]. Most CCAs are unresectable at 
presentation. Even after curative resection, 5-year sur-
vival rates of  only 11%-44% have been reported[1]. Con-
sidering the poor prognosis and increasing incidence, it 
is crucial to recognize risk factors for CCA in order to 
decrease its incidence.
Several risk factors, including liver fluke infestation[5] 
and hepatolithiasis[6,7], were identified in East Asia 
including Korea, where CCA is more prevalent than in 
Western countries[8]. However, those account for < 30% 
of  all CCA cases[1]. Recently, hepatitis B virus (HBV) 
infection[9] and diabetes mellitus (DM)[10] have been 
reported to be additional possible risk factors, but it has 
been estimated that only < 25% of  CCA cases are related 
to these factors[7,11].
DM, thyroid disease, chronic pancreatitis, hypertension, 
and ulcerative colitis. 
All data were obtained retrospectively from patient 
records. We only included information up to 1 year 
before the diagnosis of  CCA for cases and 1 year before 
the cancer diagnosis of  the index case for the matched 
controls.
Definitions of events
CCA was classified as either intrahepatic or extrahepatic 
CCA. Hilar CCA was included in ECC, and ampulla 
of  Vater cancer was excluded in this analysis. A heavy 
drinker was defined as an individual currently drinking 
alcoholic beverages in a daily amount of  ≥ 80 g (male) 
or ≥ 40 g (female)[14]. Obesity was defined as a body 
mass index of  25.0 kg/m2 or greater, according to the 
Asian-Pacific criteria for obesity[15].
Blood samples were collected from cases and con-
trols at the time of  initial examination. Serum HBV 
surface antigen (HBsAg) and HCV antibody (anti-
HCV) were assessed by using enzyme immunoassay 
(Abbott Laboratories, North Chicago, IL, United 
States), and anti-HCV-positive participants were tested 
for HCV RNA by using COBAS® Ampliprep (Roche 
Molecular Systems, Inc., CA, United States). HBV 
infection was defined as a positive hepatitis B surface 
antigen, and HCV infection was defined as a positive 
HCV RNA. The diagnostic criteria for cirrhosis were 
as follows: clinical manifestations of  chronic hepatitis 
with portal hypertension (e.g., collateral varices, varices, 
thrombocytopenia, or splenomegaly) and/or hepatic 
decompensation (e.g., jaundice, prolonged prothrombin 
time, and ascites), laboratory tests, and radiologic studies. 
In patients undergoing surgical treatment, cirrhosis was 
also confirmed pathologically. Nonspecific cirrhosis was 
defined by the presence of  cirrhosis without the presence 
of  HCV, HBV, or alcoholic liver disease.
The diagnosis of  liver fluke infestation was made 
on the basis of  detection of  ova or worms in feces, or 
radiologic finding of  diffuse, uniform dilatation of  the 
small intrahepatic bile ducts with no or minimal dilatation 
of  larger bile ducts and with no focal obstructing lesion. 
Choledochal cysts were considered to be present if  there 
was a characteristic cystic or fusiform dilatation of  the 
extrahepatic or intrahepatic duct on radiologic findings. 
Choledocholithiasis was defined as the presence of  at 
least one stone in the extrahepatic bile duct, whereas 
hepatolithiasis as the presence of  stone in the intrahepatic 
bile duct. The presence of  cystic duct stone was classified 
as cholecystolithiasis.
Diabetes was diagnosed according to the World 
Health Organization Criteria[16], and categorized into 
two groups: (1) complicated diabetes (presence of  any 
stage of  retinopathy, nephropathy or macrovascular 
complications); and (2) uncomplicated diabetes. Thyroid 
disease included hyperthyroidism and hypothyroidism.
Statistical analysis
Statistical analyses were performed by using SPSS 20.0 
(SPSS incorporated, Chicago, IL, United States). The 
Mann-Whitney U test and the Pearson χ 2 with Fisher 
exact test were used to compare continuous and discrete 
variables, respectively. Univariate and multivariate analyses 
of  correlation were carried out by using conditional 
logistic regression with maximum likelihood estimates of  
parameter values for assessing the risk for CCA. Among 
all variables investigated, primary sclerosing cholangitis, 
choledochal cyst, and nonspecific liver cirrhosis were 
not tested because cases were too few to be analyzed 
(n < 3 in whole study population including controls). 
All other variables were evaluated in the univariable 
conditional logistic regression analysis, and the variables 
with P < 0.1 in the univariate analysis were included in 
the multivariable models. The adjusted odds ratio (AOR) 
and 95%CI for each variable were estimated by using the 
logistic regression coefficient. In all analyses, P < 0.05 for 
two-sided tests was considered statistically significant.
The synergisms between risk factors were evaluated 
by including them in the additive regression model 
using an interaction term, since it is more appropriate 
to assess biological interactions and public health 
concerns. Multiple logistic regression models were used 
to evaluate departure from additivity. By crossing two 
independent risk factors for CCA, dummy variables of  
4 categories were obtained; 2 for the presence of  each 
risk factor alone, 1 for the presence of  both risk factors, 
and 1 for the absence of  both risk factors. The last of  
these categories was used as the reference category in 
the regression models. To assess the deviation from 
the additive model of  no interaction between variables, 
the Synergism index (S) and its 95%CI, as proposed 
by Rothman, was calculated[17]; S = (OR11 - 1)/(OR01 + 
OR10 - 2). OR10 and OR01 mean the OR for the presence 
of  each risk factor in the absence of  the other, whereas 
OR11 means the OR of  the joint effect of  two risk 
factors. A value of  S equal to unity was interpreted as 
indicative of  additivity, whereas a value greater than unity 
was indicative of  superadditivity and synergism.
RESULTS
Patient characteristics
There were 276 patients with CCA eligible for this study. 
Out of  these, 83 (30.1%) were ICC and 193 (69.9%) 
were ECC. The CCA patients and controls had a similar 
mean age (67.8 ± 12.5 vs 67.5 ± 12.5, P = 0.818) and 
proportion of  men (50.4% vs 50.4%, male to female ratio, 
1.02:1), suggesting that pairing was effective. 
CCA population
The multivariate conditional logistic analysis showed 
that cholecystolithiasis (AOR = 1.74; 95%CI: 1.04-2.90), 
choledocholithiasis (AOR = 12.35; 95%CI: 4.31-35.38), 
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the ECC population (P = 0.055) (Tables 2 and 3). 
Interaction between risk factors
After evaluating the independent effects of  each signi-
ficant risk factor on CCA development, the inter-actions 
and synergism of  those factors were investigated. Of  
all significant factors, hepatolithiasis was not included in 
this analysis because of  the small number of  cases and 
lack of  controls, with hepatolithiasis and other significant 
risk factors together. Every pair of  other significant risk 
factors was analyzed with adjustment for the rest of  
the significant factors. When investigating interactions 
between diabetes and HBV infection on the risk of  CCA, 
the relative excess risk of  developing CCA in patients 
having DM and HBV infection together exceeded the 
sum of  the relative excess risks for each risk factor alone: 
12.2-1.0 > (2.5-1.0) + (3.5-1.0). The estimated synergism 
index (S) was 2.80 (95%CI: 1.54-5.08), indicating the joint 
effect of  DM and HBV infection is superadditive (Table 
4, Figure 1A). When including only complicated diabetes 
instead of  the entire diabetic cases in this analysis, the 
synergistic effect on the risk of  CCA was greater than the 
effect between DM and HBV infection. The estimated 
synergism index (S) was 8.12 (95%CI: 4.92-13.38) (Table 
4). These superadditivities of  the joint effect between 
DM and HBV infection, or complicated DM and HBV 
infection were also investigated in the ICC subgroup 
population. The estimated synergism index (S) between 
DM and HBV infection, and complicated DM and 
HBV infection was 2.44 and 5.45, respectively (Table 5, 
Figure 1B). However, there was no synergistic interaction 
between other significant risk factors for CCA and ICC. 
Similarly, no significant interaction was observed between 
hepatolithiasis (AOR = 39.87; 95%CI: 7.25-219.17), HBV 
infection (AOR = 4.12; 95%CI: 2.01-8.44), and DM (AOR 
= 2.55; 95%CI: 1.66-3.91) were the significant risk factors 
for CCA (Table 1). HCV infection and heavy alcohol 
consumption were not significantly associated with 
development of  CCA. When DM was dichotomized into 
complicated and uncomplicated DM, complicated DM 
resulted in a greater risk of  CCA than uncomplicated 
DM (AOR = 3.25 and 2.20, respectively) (Table 1). 
However, there is no significant correlation between 
estimated AOR and duration of  DM (AOR = 1.42 and 
0.75 for 5-10 years and > 10 years, respectively, P = 0.5).
Subgroup analysis- ECC and ICC population
Subgroup analysis was performed to investigate risk 
factors for ECC and ICC development. We included 
193 ECC patients and 386 controls, and 83 ICC patients 
and 166 controls in the conditional logistic regression 
model. When ECC and ICC cases were compared to 
their respective control participants, cholecystolithiasis, 
choledocholithiasis, hepatolithiasis, and DM were the 
significant risk factors for ECC (AOR = 2.01, 18.08, 
14.87 and 1.99, respectively) (Table 2), whereas chole-
docholithiasis, hepatolithiasis, HBV infection, and DM 
were the significant risk factors for ICC development 
(AOR = 8.63, 157.37, 5.27, and 4.87, respectively) (Table 
3). Cholecystolithiasis was the significant risk factor for 
ECC but not ICC development. However, DM was 
significantly associated with both ECC and ICC. As with 
the results in the entire CCA population, complicated DM 
also resulted in a greater risk of  CCA than uncomplicated 
DM in both subgroup analyses, although AOR for 
uncomplicated DM did not reach statistical significance in 
505 January 14, 2015|Volume 21|Issue 2|WJG|www.wjgnet.com
Table 1  Comparison of risk factors in patients with cholangiocarcinoma and matched controls   n  (%)
Variable CCA patient (n  = 276) Control (n  = 552) Univariable analysis Multivariable analysis
OR (95%CI) P  value AOR (95%CI) P  value
Cigarette smoking   84 (30.4) 157 (28.4) 1.14 (0.79-1.66)    0.487 - -
< 20 pack-years1   35 (12.7) 53 (9.6) 1.39 (0.85-2.27)    0.191 - -
≥ 20 pack-years   49 (17.8) 104 (18.8) 1.01 (0.66-1.55)    0.972 - -
Heavy alcohol consumption2   35 (12.7) 50 (9.1) 1.53 (0.94-2.51)    0.088 1.45 (0.82-2.55)    0.199
Obesity3   64 (23.2) 134 (24.3) 0.94 (0.66-1.33)    0.722 - -
Cholecystolithiasis   47 (17.0) 42 (7.6) 2.34 (1.52-3.61) < 0.001 1.74 (1.04-2.90)    0.035
Choledocholithiasis   34 (12.3)   7 (1.3) 13.31 (5.20-34.07) < 0.001 12.35 (4.31-35.38) < 0.001
Hepatolithiasis 20 (7.2)   1 (0.2) 20.00 (4.68-85.57) < 0.001   39.87 (7.25-219.17) < 0.001
Cholecystectomy 17 (6.2) 23 (4.2) 1.49 (0.79-2.82)    0.216 - -
Ulcerative colitis   2 (0.7)   3 (0.5) 1.33 (0.22-7.98)    0.753 - -
Alcoholic liver disease 14 (5.1) 26 (4.7) 1.08 (0.55-2.13)    0.816 - -
Thyroid disease   6 (2.2) 22 (4.0) 0.51 (0.20-1.31)    0.164 - -
Chronic pancreatitis   1 (0.4)   5 (0.9) 0.40 (0.05-3.42)    0.403 - -
Hypertension 113 (40.9) 254 (46.0) 0.80 (0.59-1.08)    0.150 - -
Diabetes mellitus   65 (23.6)   69 (12.5) 2.22 (1.51-3.28) < 0.001 2.55 (1.66-3.91) < 0.001
   Without complications   36 (13.0) 47 (8.5) 1.82 (1.12-2.96)    0.015 2.20 (1.30-3.70)    0.003
   With complications4   29 (10.5) 22 (4.0) 2.98 (1.67-5.32) < 0.001 3.25 (1.69-6.25) < 0.001
HBV infection   28 (10.1) 18 (3.3) 3.34 (1.80-6.19) < 0.001 4.12 (2.01-8.44) < 0.001
HCV infection 11 (4.0) 13 (2.4) 1.69 (0.76-3.78)    0.199 - -
Liver fluke infestation   6 (2.2)   4 (0.7)   3.00 (0.85-10.63)    0.089 3.49 (0.86-14.07)    0.079
1One pack-year = 1 pack per day for a year; 2Daily amount of ≥ 80 g (male) or ≥ 40 g (female); 3Obesity was defined as a body mass index > 25 kg/m2 
according to the Asian-Pacific criteria for obesity; 4Any stage of retinopathy, nephropathy or macrovascular complications. CCA: Cholangiocarcinoma; 
HBV: Hepatitis B virus; HCV: Hepatitis C virus; AOR: Adjusted odds ratio.
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significant risk factors for ECC. Only one ECC patient 
had DM and HBV infection, simultaneously. 
DISCUSSION
The etiology and carcinogenesis of  CCA remains 
obscure despite several established risk factors. In the 
present hospital based case-control study in Korea, 
we confirmed that HBV infection and DM were inde-
pendent risk factors for CCA, particularly for ICC deve-
lopment, and found that there was a synergistic inter-
action between these factors regarding the risk of  CCA. 
In the multivariate conditional logistic regression analysis, 
choledocholithiasis, hepatolithiasis, and DM were 
significantly associated with both ECC and ICC, whereas 
HBV infection and cholecystolithiasis were risk factors 
only for ICC and ECC development, respectively.
Our investigation of  positive association between 
HBV infection and ICC was consistent with previous 
reports[7,18]. Previous studies demonstrated that both 
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Table 2  Comparison of risk factors in patients with extrahepatic cholangiocarcinoma and matched controls  n  (%)
Variable ECC patient (n  = 193) Control (n  = 386) Univariable analysis Multivariable analysis
OR (95%CI) P  value AOR (95%CI) P  value
Cigarette smoking   53 (27.5)   91 (23.6) 1.32 (0.83-2.10)    0.240 - -
< 20 pack-years   20 (10.4) 30 (7.8) 1.51 (0.79-2.87)    0.212 - -
≥ 20 pack-years   33 (17.1)   61 (15.8) 1.23 (0.73-2.08)    0.444 - -
Heavy alcohol consumption 18 (9.3) 24 (6.2) 1.62 (0.83-3.17)    0.161 - -
Obesity   42 (21.8)   90 (23.3) 0.91 (0.59-1.40)    0.658 - -
Cholecystolithiasis   33 (17.1) 28 (7.3) 2.49 (1.48-4.20)    0.001 2.01 (1.12-3.58)    0.019
Choledocholithiasis   24 (12.4)   2 (0.5)   24.00 (5.67-101.55) < 0.001 18.08 (4.18-78.19) < 0.001
Hepatolithiasis   9 (4.7)   1 (0.3)   18.00 (2.28-142.08)    0.006   14.87 (1.79-123.74)    0.013
Cholecystectomy 13 (6.7) 19 (4.9) 1.38 (0.67-2.84)    0.376 - -
Ulcerative colitis   2 (1.0)   1 (0.3)   4.00 (0.36-44.11)    0.258 - -
Alcoholic liver disease   7 (3.6) 13 (3.4) 1.08 (0.42-2.78)    0.871 - -
Thyroid disease   5 (2.6) 15 (3.9) 0.64 (0.22-1.84)    0.408 - -
Chronic pancreatitis   1 (0.5)   5 (1.3) 0.40 (0.05-3.42)    0.403 - -
Hypertension   84 (43.5) 185 (47.9) 0.83 (0.58-1.19)    0.301 - -
Diabetes mellitus   44 (22.8)   54 (14.0) 1.88 (1.19-2.98)    0.007 1.99 (1.22-3.27)    0.006
   Without complications   27 (14.0) 38 (9.8) 1.64 (0.95-2.85)    0.077 1.78 (0.99-3.19)    0.055
   With complications 17 (8.8) 16 (4.1) 2.43 (1.18-5.00)    0.016 2.48 (1.16-5.32)    0.020
HBV infection   9 (4.7)   9 (2.3) 2.10 (0.80-5.49)    0.131 - -
HCV infection   6 (3.1) 10 (2.6) 1.20 (0.44-3.30)    0.724 - -
Liver fluke infestation   3 (1.6)   2 (0.5)   3.00 (0.50-17.95)    0.229 - -
HBV: Hepatitis B virus; HCV: Hepatitis C virus; ECC: Extrahepatic cholangiocarcinoma.
Table 3  Comparison of risk factors in patients with intrahepatic cholangiocarcinoma and matched controls  n  (%)
Variable ICC patient (n  = 83) Control (n  =166) Univariable analysis Multivariable analysis
OR (95%CI) P  value AOR (95%CI) P  value
Cigarette smoking 31 (37.3)   66 (39.8) 0.87 (0.47-1.63)    0.670 - -
< 20 pack-years 15 (18.1)   23 (13.9) 1.17 (0.54-2.51)    0.689 - -
≥ 20 pack-years 16 (19.3)   43 (25.9) 0.68 (0.33-1.44)    0.318 - -
Heavy alcohol consumption 17 (20.5)   26 (15.7) 1.44 (0.70-2.97)    0.319 - -
Obesity 22 (26.5)   44 (26.5) 1.00 (0.56-1.80)    0.999 - -
Cholecystolithiasis 14 (16.9) 14 (8.4) 2.06 (0.96-4.41)    0.062   1.04 (0.33-3.29) 0.941
Choledocholithiasis 10 (12.0)   4 (2.4)   6.20 (1.70-22.71)    0.006     8.63 (1.30-57.33) 0.026
Hepatolithiasis 11 (13.3)   1 (0.6)   22.00 (2.84-170.40)    0.003 157.37 (9.36-2646) < 0.001
Cholecystectomy 4 (4.8)   4 (2.4) 2.00 (0.50-8.00)    0.327 - -
Ulcerative colitis 0 (0.0)   2 (1.2)   0.03 (0.0-5748.1)    0.561 - -
Alcoholic liver disease 7 (8.4) 13 (7.8) 1.09 (0.41-2.87)    0.868 - -
Thyroid disease 1 (1.2)   7 (4.2) 0.25 (0.03-2.19)    0.211 - -
Chronic pancreatitis 0 (0.0)   0 (0.0) - - - -
Hypertension 29 (34.9)   69 (41.6) 0.73 (0.41-1.31)    0.291 - -
Diabetes mellitus 21 (25.3) 15 (9.0) 3.34 (1.60-7.01)    0.001 4.87 (1.88-12.59) 0.001
   Without complications   9 (10.8)   9 (5.4) 2.52 (0.90-7.03)    0.078 4.00 (1.18-13.61) 0.027
   With complications 12 (14.5)   6 (3.6)   4.28 (1.59-11.49)    0.004 6.13 (1.57-24.00) 0.009
HBV infection 19 (22.9)   9 (5.4)   4.58 (2.00-10.50) < 0.001 5.27 (1.93-14.38) 0.001
HCV infection 5 (6.0)   3 (1.8)   3.33 (0.80-13.95)    0.099 1.71 (0.25-11.45) 0.582
Liver fluke infestation 3 (3.6)   2 (1.2)   3.00 (0.50-17.95)    0.229 - -
HBV: Hepatitis B virus; HCV: Hepatitis C virus; ICC: Intrahepatic cholangiocarcinoma.
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hepatocytes and cholangiocytes differentiate from the 
same hepatic progenitor cells; therefore, it is possible that 
HBV induces carcinogenesis in cholangiocytes through 
a similar mechanism as in hepatocytes[19,20]. In addition, 
HBV may be involved in the pathogenesis of  ICC 
through a chronic inflammatory process[21,22]. Chronic 
inflammation of  the biliary epithelium evoked by HBV 
infection can render it vulnerable to immunologic attack, 
leading to genetic alterations and subsequent malignant 
transformations of  cells[23].
In contrast with HBV infection, HCV infection was 
not a significant risk factor for ICC in this investigation. 
This finding is in accordance with a previous Korean 
study[7]. Similarly, a recent meta-analysis did not identify 
a significant association between ICC development and 
HCV infection when analyzed in relation to East-Asian 
populations, whereas it did indicate a strong association 
(OR = 6.91) in relation to Western populations[18]. 
However, considering the small number of  studies and 
participants analyzed, an additional large-scale study of  
Eastern regions is warranted to confirm the geographic 
variation.
Our results also indicated significant association 
between DM and CCA development, which is com-
patible with previous studies[7,18]. Insulin resistance and 
hyperinsulinemia have been shown to stimulate the 
growth of  numerous cancer cell lines[24]. In addition, 
upregulated insulin-like growth factor 1 may stimulate 
liver cell proliferation, consequently leading to carci-
nogenesis of  CCA[25,26]. 
For a more precise assessment, analyses were re-
peated after subclassifying all diabetic cases according to 
duration and the presence of  complications. Although 
the duration of  DM was not significantly correlated 
with the CCA risk, the impact of  DM on the risk of  
CCA was greater when DM complications were present. 
Considering long time interval between actual DM 
onset and its clinical diagnosis[27], disease duration from 
diagnosis does not reflect the exact duration of  illness. 
Moreover, control of  DM and severity of  the disease may 
be more crucial predictors than mere disease duration. 
Notably, occurrence of  DM complications depends on 
glucose control and actual disease duration[28]. To clearly 
elucidate the impact of  the duration of  DM on the risk 
of  CCA development, a future well-designed study with 
more detailed information is needed.
In this study, there were several interesting findings 
regarding the association between cholelithiasis and 
CCA: (1) cholecystolithiasis was a risk factor for ECC, 
but not ICC; (2) choledocholithiasis was a risk factor for 
both ECC and ICC; and (3) hepatolithiasis was a risk 
factor not only for ICC, but also for ECC. These results 
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Table 4  Interaction between diabetes mellitus and hepatitis B virus infection for cholangiocarcinoma: logistic regression analysis 
with adjusted odds ratio
Interaction variables n β  Coefficient (± SE) P  value AOR1 (95%CI) S (95%CI)2
DM HBV
   Negative Negative 658 1
   Positive Negative 124 0.909 (0.22) < 0.001 2.5 (1.6-3.8)
   Negative Positive   36 1.259 (0.39)    0.001 3.5 (1.6-7.6)
   Positive Positive   10 2.502 (0.96)    0.009 12.2 (1.9-80.1) 2.80 (1.54-5.08)
Complicated DM HBV
   Negative Negative 740 1
   Positive Negative   42 0.967 (0.34)    0.005 2.6 (1.3-5.1)
   Negative Positive   37 1.107 (0.38)    0.004 3.0 (1.4-6.4)
   Positive Positive     9 3.423 (1.32)    0.009   30.7 (2.3-403.4) 8.12 (4.92-13.38)
1AOR: Odds ratio adjusted for the other significant risk factors for cholangiocarcinoma; 2S = Synergy index described by Rothman = (OR11 - 1)/(OR01 + OR10 
- 2), where OR11 = OR of the joint effect of 2 risk factors; OR01 and OR10 = OR of each risk factor in the absence of the other. DM: Diabetes mellitus; HBV: 
Hepatitis B virus; AOR: Adjusted odds ratio.
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Figure 1  Risk of cholangiocarcinoma in subjects with diabetes mellitus, hepatitis B virus infection, or both. A: Whole cholangiocarcinoma population; B: 
Intrahepatic cholangiocarcinoma population. DM: Diabetes mellitus; HBV: Hepatitis B virus infection; R: Common reference category.
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may be explained by the effects of  cholestasis, altered 
bile composition, and chronic proliferative inflammation 
near the stone-bearing ducts. Among the 9 patients with 
ECC who had hepatolithiasis in our study population, 7 
patients had hilar cholangiocarcinoma, which supports 
this explanation. Previous Chinese studies showed the 
association between hepatolithiasis and ECC as well[29,30], 
which also supports our results.
The most noteworthy finding of  this study is the 
synergistic effect between DM and HBV infection on 
the risk of  CCA development. Although the definite 
mechanism is uncertain, there is a possible explanation 
for the interaction. Hyperglycemia could stimulate 
glucose oxidation, lipid peroxidation, and glycosylation 
of  proteins, which leads to production of  free radicals 
causing oxidative stress[31]. Oxidative stress subsequently 
may promote HBV gene expression, reactivation of  
viral replication, and liver disease chronicity, leading to 
DNA damage and CCA development[32,33]. Considering 
that oxidative stress is a widely accepted key mediator 
in the progression of  DM and its complications[31,34], 
our finding of  greater synergism between complicated 
DM and HBV infection support this explanation. It is 
considered that CCA and HCC share common etiologic 
factors, and a previous study on the risk factors for HCC 
also indicated the synergistic interaction between DM and 
HBV infection on cancer development[35,36], supporting 
our finding as well.
The present study has several potential limitations: (1) 
diagnostic bias cannot be excluded because cancer patients 
undergo additional testing, and thus may have more 
diagnoses than individuals without cancer; (2) this was a 
hospital-based study performed in a single institution, not 
a population-based design, therefore there is a possibility 
of  selection bias caused by differential referral patterns; 
however, hospital-based design may be more appropriate 
for CCA in view of  the low incidence and short survival 
of  CCA patients; (3) hepatitis B core antibody (anti-
HBc) and occult HBV infection were not investigated 
in this study; however, recent studies demonstrated very 
low levels of  HBV DNA in subjects with anti-HBc alone 
(without surface antigen/antibody), and extremely low 
incidence of  occult HBV infection[37,38]. Furthermore, the 
prevalence of  HBV observed in the present study was 
comparable with the previous HBV prevalence estimates 
in Korea[39]; and (4) DM was not classified according 
to type; considering the absence of  young-onset (≤ 30 
years) DM in our cohort and extremely lower incidence 
of  type Ⅰ DM in Asia[40], most of  the DM cases in this 
study were thought to be type 2 DM.
Despite these limitations, our study has several note-
worthy strengths: (1) this is the first analysis of  risk factors 
for ECC in Korea that was conducted after adjustment 
for possible confounding risk factors in a multivariable 
model. A previous Korean study[41] focused only on 
Clonorchis sinensis parasitosis as a risk factor for ECC with-
out adjustment for confounders; (2) the prevalence of  
the significant risk factors in the control subjects was 
comparable with the prevalence in the general population 
of  Korea[42,43] or other Asian country[44]; (3) we stratified 
biliary lithiasis and DM according to the location and the 
presence of  the complication, respectively. To the best 
of  our knowledge, this is the first study to investigate the 
impact of  complicated and uncomplicated DM on CCA 
risk, after stratification of  DM; and (4) most importantly, 
this is the first study to investigate the synergistic effect 
between DM and HBV infection on the risk of  CCA 
development. This “new” finding may help stratify 
patients at risk for CCA and design CCA surveillance 
algorithms depending on the stratification.
In conclusion, besides the biliary lithiasis, HBV 
infection and DM were independent risk factors for 
CCA, especially for ICC development. In addition, there 
was synergistic interaction between the two factors on the 
risk for CCA development. A further large-scale study is 
warranted to confirm this synergistic interaction and to 
clarify possible underlying mechanisms. Exploring the 
underlying mechanisms for such synergy may lead to the 
development of  CCA prevention strategies in high-risk 
individuals.
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Table 5  Interaction between diabetes mellitus and hepatitis B virus infection for intrahepatic cholangiocarcinoma: logistic regression 
analysis with adjusted odds ratio
Interaction variables n β  Coefficient (± SE) P  value AOR1 (95%CI) S (95%CI)
DM HBV
Negative Negative 194 1
Positive Negative 27 1.670 (0.51) 0.001 5.3 (2.0-14.3)
Negative Positive 19 1.718 (0.58) 0.003 5.6 (1.8-17.4)
Positive Positive 9 3.120 (1.15) 0.006 22.7 (2.4-214.1) 2.44 (1.30-4.58)
Complicated DM HBV
Negative Negative 211 1
Positive Negative 10 1.660 (0.77) 0.031 5.3 (1.2-23.8)
Negative Positive 20 1.528 (0.56) 0.006 4.6 (1.5-13.7)
Positive Positive 8 3.782 (1.51) 0.012 43.9 (2.3-849.5) 5.45 (3.16-9.42)
1AOR: Odds ratio adjusted for the other significant risk factors for intrahepatic cholangiocarcinoma. DM: Diabetes mellitus; HBV: Hepatitis B virus; AOR: 
Adjusted odds ratio; S: Synergism index.
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